HAIR

We offer a variety of hair options for women and men ranging from basic cut and style to highlights, gloss, treatments and more.

Learn More

NAILS

From pedicure and manicures to acrylic nails and toes we have just the right option to help you look your best.

Learn More

SPA

Everyone deserves to be pampered. We can  help you relax and rejuvenate w/ a facial, massage or with one of our spa packages.

Learn More

S End -Initial Data from Reducer Patient Registries To Be Presented at EuroPCR 2013 Neovasc Inc.

COSIRA trial: Enrollment complete for assessing Neovasc Reducer in refractory angina patients -Complete Data from COSIRA Trial Expected Around Year's End – -Initial Data from Reducer Patient Registries To Be Presented at EuroPCR 2013 – Neovasc Inc tadalafil 20mg generic http://tadacip20mg.org . The COSIRA trial is normally a double-blinded, randomized, sham-controlled multicenter trial designed to demonstrate the efficacy of the Reducer in a managed people of refractory angina individuals. It was conducted in the UK, Europe and Canada. COSIRA was designed as a rigorous study to provide definitive proof the efficacy of the Reducer in enhancing the standard of life of individuals with refractory angina, and we look forward to sharing six-month follow-up data from the trial in a peer-reviewed forum around yr's end, said Shmuel Banai, MD, Chief Medical Officer of Neovasc.